What is Keeps?
Keeps operates as a specialized telehealth platform dedicated to the prevention and treatment of male pattern baldness. By providing a streamlined, direct-to-consumer model, the company offers FDA-approved medications such as Finasteride and Minoxidil, coupled with ongoing support from licensed medical professionals. This approach effectively removes traditional barriers to entry for men seeking hair loss solutions, positioning Keeps as a leader in the intersection of pharmaceutical delivery and consumer wellness. The company's commitment to affordable, convenient, and expert-led care has allowed it to capture a significant share of the men's health market, transforming how patients engage with long-term treatment plans.
How much funding has Keeps raised?
Keeps has raised a total of $15.3M across 2 funding rounds:
Series A
$15.3M
Debt
$31K
Series A (2018): $15.3M with participation from Greycroft Partners, First Round Capital, HillCour, Maveron, ERA, Two River, Northzone, and Steadfast Venture Capital
Debt (2021): $31K led by PPP
Key Investors in Keeps
Greycroft Partners
Greycroft is a leading venture capital firm focused on investments in the Internet and mobile markets, leveraging an extensive network to help entrepreneurs build successful, high-visibility businesses.
First Round Capital
A venture capital firm that invests in innovative startups across various sectors, focusing on supporting entrepreneurs to achieve significant market results and successful exits.
Maveron
A consumer-only venture capital firm that partners with innovative entrepreneurs to transform consumer experiences, with a focus on early-stage brands that prioritize human behavior and technological disruption.
What's next for Keeps?
With the recent deployment of $31K, Keeps is well-positioned to accelerate its strategic expansion. The company is expected to focus on deepening its product portfolio, potentially extending its reach into broader sexual health and wellness categories. As the firm transitions from its initial scaling phase into a more mature enterprise-level operation, the focus will likely shift toward optimizing patient retention through enhanced digital health tools and expanding its logistical capabilities to maintain its competitive edge in the direct-to-consumer pharmaceutical space.
See full Keeps company page
